Archive for the ‘webinar’ Category

Webinar Series: Safety Biomarkers in Drug Development

Friday, August 7th, 2009

 

 

The ability to accurately predict adverse events related to areas like cardiology, nephrology, neurology, haematology and hepatology is extremely exciting. Validated safety biomarkers provide the opportunity for smarter and earlier decision making in R&D, meaning project „kill“ decisions are made quicker, later-stage projects become less risky and hundreds of millions of dollars can be saved.

This webinar will summarise what are the most innovative recent scientific developments and the most promising regulatory initiatives, as well as providing a platform for partnering amongst the pharma, biotech, diagnostics and academic sectors.

Why attend?

 

  • Understand the regulatory requirements to demonstrate safety through biomarkers.
  • Make partnerships and alliances with biomarker R&D experts.
  • Gain access to the latest successful biomarker development case studies.
  • Review multi-stakeholders perspectives: pharma, regulators, research institutes, academia & solution providers.
  • Learn how to integrate biomarker knowledge in monitoring safety in drug development to reduce risk.
  • Identify and understand better, advanced cardiac, renal, hepatological and neurological risk markers.
  • Discover cutting-edge approaches for identification and development of new markers.

Who will benefit:

Pharmaceutical, Biotech, Diagnostic & Academic research organisations:
CEOs / Vice-Presidents / Heads / CSOs / Managers / Professors and Scientists involved in: R&D, drug safety & pharmacovigilance, biomarker discovery/validation, molecular diagnostics, pharmacogenomics/genetics/proteomics, translational medicine, clinical science and development, molecular imaging, pre-clinical development, modeling and simulation, pharmacology, pharmacokinetics/pharmacodynamics

Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads

 

Agenda Request

To request the full agenda please follow the link:

https://www.nextlevelpharma.com/events/request_agenda/safety_biomarkers_in_drug_development

Contact Details:

For Booking Information:

Tel: +421 232 662 621

Fax: +421 232 660 395
Email: erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com

Improving Drug Design for Children

Thursday, July 16th, 2009

pediatric_banner.jpg

This will be a half day webinar for clinical pharmacologists, scientists and pediatricians to discuss overcoming the scientific challenges in designing PK/PD studies to aid developing new pediatric medicines.

NextLevel Pharma’s focused and interactive webinar will look to concentrate on the position that pharmacokinetic and pharmacodynamic modelling and simulations have to answer the questions of how children metabolize drugs differently, how to assess optimal drug dosage levels and optimise the design of pediatric studies.

Experienced industry pharmacologists and pediatricians will join us to discuss recent developments and assess how to better understand drug interaction, determine the optimal dosage and report on efficacy in children.

Why participate?

  • Understand the need for pk/pk studies: the when, how and why in the eyes of the regulators.
  • Learn what roles pk/pd studies have in the development of pediatric drugs and how they can be used more effectively to determine dosages, measure efficacy and demonstrate value to the pediatric world.
  • Hear case study presentations from industry leaders on how to adapt methods used from adult to children and gain fresh perspectives from experienced pharmaceutical companies who have successfully integrated pk/pd into pediatric studies for optimal design.
  • Discover which approaches are best to predict dosage, utilize existing (adult) data, and understand the interactions between drug and child.

Who will benefit:

Pharmaceutical & Biotechnology Organisations:
Vice- Presidents, Directors, Managers;
Pediatrics, Pre-Clinical and Clinical Pharmacologists, Modelling and simulation specialists.

Academics;
Pediatricians, pharmacologists and scientists involved in the development of new pediatric medicines

Agenda Request

To request the full agenda please follow the link:

https://www.nextlevelpharma.com/events/request_agenda/pediatric_pharmacology

Contact Details:

For Booking Information:

Tel: +421 232 662 621

Fax: +421 232 662 622

Email: erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com